338 related articles for article (PubMed ID: 20138518)
1. Preparation and in vitro screening of symmetrical bispyridinium cholinesterase inhibitors bearing different connecting linkage-initial study for Myasthenia gravis implications.
Musilek K; Komloova M; Zavadova V; Holas O; Hrabinova M; Pohanka M; Dohnal V; Nachon F; Dolezal M; Kuca K; Jung YS
Bioorg Med Chem Lett; 2010 Mar; 20(5):1763-6. PubMed ID: 20138518
[TBL] [Abstract][Full Text] [Related]
2. Preparation and in vitro screening of symmetrical bis-isoquinolinium cholinesterase inhibitors bearing various connecting linkage--implications for early Myasthenia gravis treatment.
Musilek K; Komloova M; Holas O; Hrabinova M; Pohanka M; Dohnal V; Nachon F; Dolezal M; Kuca K
Eur J Med Chem; 2011 Feb; 46(2):811-8. PubMed ID: 21236521
[TBL] [Abstract][Full Text] [Related]
3. Preparation, in vitro screening and molecular modelling of symmetrical bis-quinolinium cholinesterase inhibitors--implications for early myasthenia gravis treatment.
Komloova M; Musilek K; Horova A; Holas O; Dohnal V; Gunn-Moore F; Kuca K
Bioorg Med Chem Lett; 2011 Apr; 21(8):2505-9. PubMed ID: 21397501
[TBL] [Abstract][Full Text] [Related]
4. The preparation, in vitro screening and molecular docking of symmetrical bisquaternary cholinesterase inhibitors containing a but-(2E)-en-1,4-diyl connecting linkage.
Musilek K; Pavlikova R; Marek J; Komloova M; Holas O; Hrabinova M; Pohanka M; Dohnal V; Dolezal M; Gunn-Moore F; Kuca K
J Enzyme Inhib Med Chem; 2011 Apr; 26(2):245-53. PubMed ID: 21406034
[TBL] [Abstract][Full Text] [Related]
5. Preparation, in vitro screening and molecular modelling of symmetrical 4-tert-butylpyridinium cholinesterase inhibitors--analogues of SAD-128.
Musilek K; Roder J; Komloova M; Holas O; Hrabinova M; Pohanka M; Dohnal V; Opletalova V; Kuca K; Jung YS
Bioorg Med Chem Lett; 2011 Jan; 21(1):150-4. PubMed ID: 21144749
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of a new series of berberine derivatives as dual inhibitors of acetylcholinesterase and butyrylcholinesterase.
Huang L; Luo Z; He F; Lu J; Li X
Bioorg Med Chem; 2010 Jun; 18(12):4475-84. PubMed ID: 20471843
[TBL] [Abstract][Full Text] [Related]
7. Preparation, in vitro evaluation and molecular modelling of pyridinium-quinolinium/isoquinolinium non-symmetrical bisquaternary cholinesterase inhibitors.
Komloova M; Horova A; Hrabinova M; Jun D; Dolezal M; Vinsova J; Kuca K; Musilek K
Bioorg Med Chem Lett; 2013 Dec; 23(24):6663-6. PubMed ID: 24220173
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, biological activity, and docking studies of new acetylcholinesterase inhibitors of the bispyridinium type.
Kapková P; Stiefl N; Sürig U; Engels B; Baumann K; Holzgrabe U
Arch Pharm (Weinheim); 2003 Nov; 336(11):523-40. PubMed ID: 14639745
[TBL] [Abstract][Full Text] [Related]
9. Cholinesterase inhibitors: xanthostigmine derivatives blocking the acetylcholinesterase-induced beta-amyloid aggregation.
Belluti F; Rampa A; Piazzi L; Bisi A; Gobbi S; Bartolini M; Andrisano V; Cavalli A; Recanatini M; Valenti P
J Med Chem; 2005 Jun; 48(13):4444-56. PubMed ID: 15974596
[TBL] [Abstract][Full Text] [Related]
10. Monooxime-monocarbamoyl Bispyridinium Xylene-Linked Reactivators of Acetylcholinesterase-Synthesis, In vitro and Toxicity Evaluation, and Docking Studies.
Musilek K; Holas O; Misik J; Pohanka M; Novotny L; Dohnal V; Opletalova V; Kuca K
ChemMedChem; 2010 Feb; 5(2):247-54. PubMed ID: 20058292
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and evaluation of flavonoid derivatives as potent AChE inhibitors.
Sheng R; Lin X; Zhang J; Chol KS; Huang W; Yang B; He Q; Hu Y
Bioorg Med Chem; 2009 Sep; 17(18):6692-8. PubMed ID: 19692250
[TBL] [Abstract][Full Text] [Related]
12. Suitability of human butyrylcholinesterase as therapeutic marker and pseudo catalytic scavenger in organophosphate poisoning: a kinetic analysis.
Aurbek N; Thiermann H; Eyer F; Eyer P; Worek F
Toxicology; 2009 May; 259(3):133-9. PubMed ID: 19428953
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationship of quaternary acetylcholinesterase inhibitors - outlook for early myasthenia gravis treatment.
Komloova M; Musilek K; Dolezal M; Gunn-Moore F; Kuca K
Curr Med Chem; 2010; 17(17):1810-24. PubMed ID: 20345342
[TBL] [Abstract][Full Text] [Related]
14. Isosorbide-2-carbamate esters: potent and selective butyrylcholinesterase inhibitors.
Carolan CG; Dillon GP; Gaynor JM; Reidy S; Ryder SA; Khan D; Marquez JF; Gilmer JF
J Med Chem; 2008 Oct; 51(20):6400-9. PubMed ID: 18817366
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and biological evaluation of conformationally restricted rivastigmine analogues.
Bolognesi ML; Bartolini M; Cavalli A; Andrisano V; Rosini M; Minarini A; Melchiorre C
J Med Chem; 2004 Nov; 47(24):5945-52. PubMed ID: 15537349
[TBL] [Abstract][Full Text] [Related]
16. Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Brunhofer G; Fallarero A; Karlsson D; Batista-Gonzalez A; Shinde P; Gopi Mohan C; Vuorela P
Bioorg Med Chem; 2012 Nov; 20(22):6669-79. PubMed ID: 23062825
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological activity of pyridinium-type acetylcholinesterase inhibitors.
Alptüzün V; Kapková P; Baumann K; Erciyas E; Holzgrabe U
J Pharm Pharmacol; 2003 Oct; 55(10):1397-404. PubMed ID: 14607022
[TBL] [Abstract][Full Text] [Related]
18. Acetylcholinesterase inhibitors: synthesis and structure-activity relationships of omega-[N-methyl-N-(3-alkylcarbamoyloxyphenyl)- methyl]aminoalkoxyheteroaryl derivatives.
Rampa A; Bisi A; Valenti P; Recanatini M; Cavalli A; Andrisano V; Cavrini V; Fin L; Buriani A; Giusti P
J Med Chem; 1998 Oct; 41(21):3976-86. PubMed ID: 9767635
[TBL] [Abstract][Full Text] [Related]
19. 4-Aryl-4-oxo-N-phenyl-2-aminylbutyramides as acetyl- and butyrylcholinesterase inhibitors. Preparation, anticholinesterase activity, docking study, and 3D structure-activity relationship based on molecular interaction fields.
Vitorović-Todorović MD; Juranić IO; Mandić LM; Drakulić BJ
Bioorg Med Chem; 2010 Feb; 18(3):1181-93. PubMed ID: 20061157
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of physostigmine analogues and evaluation of their anticholinesterase activities.
Zhan ZJ; Bian HL; Wang JW; Shan WG
Bioorg Med Chem Lett; 2010 Mar; 20(5):1532-4. PubMed ID: 20144867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
